Xerox 5400 用户指南
98
Xerox Phaser 5400 Laser Printer
Sp
ecific
at
ion
s
Section 2 - Emergency and First Aid
Primary Route of Entry: Inhalation
Eyes: Flush with water for several minutes.
Skin: Wash with soap and water.
Inhalation: Remove from exposure.
Ingestion: Dilute stomach contents with several glasses of milk or water.
Symptoms of Overexposure: Minimal respiratory tract irritation may occur as
Eyes: Flush with water for several minutes.
Skin: Wash with soap and water.
Inhalation: Remove from exposure.
Ingestion: Dilute stomach contents with several glasses of milk or water.
Symptoms of Overexposure: Minimal respiratory tract irritation may occur as
with exposure to large amounts of any non-toxic dust.
Medical Conditions Generally Aggravated by Exposure: None
Additional Information: None
Medical Conditions Generally Aggravated by Exposure: None
Additional Information: None
Section 3 - Toxicology and Health Information
This material has been evaluated by Xerox Corporation. The toxicity data
noted below is based on the test results of similar xerographic toners.
Oral LD
Oral LD
50
: >5 g/kg (rats) practically non-toxic.
Dermal LD
50
: >5 g/kg (rabbits) practically non-toxic.
Inhalation LC
50
: >2.0 mg/l (rats, 4 hour exposure) practically non-toxic.
Eye Irritation: Non-irritating.
Skin Sensitization: Not a sensitizer.
Skin Irritation: Not an irritant.
Human Patch: Non-irritating, non-sensitizing.
Mutagenicity: No mutagenicity detected in Ames Assay.
Carcinogens: None present.
Aquatic LC
Skin Sensitization: Not a sensitizer.
Skin Irritation: Not an irritant.
Human Patch: Non-irritating, non-sensitizing.
Mutagenicity: No mutagenicity detected in Ames Assay.
Carcinogens: None present.
Aquatic LC
50
: >1000 mg/l (fathead minnows) non-toxic.
TLV: 10 mg/m
3
(total dust)
PEL: 15 mg/m
3
(total dust) 5 mg/m
3
(respirable dust)
STEL: None Established
Ceiling: None Established
Xerox Exposure Limit: 2.5 mg/m
Ceiling: None Established
Xerox Exposure Limit: 2.5 mg/m
3
(total dust) 0.4 mg/m
3
(respirable dust)